2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
about
Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemCervical cancer screening: A never-ending developing programThe Pap test and Bethesda 2014Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screeningPractical issues related to uterine pathology: in situ and invasive cervical glandular lesions and their benign mimics: emphasis on cytology-histology correlation and interpretive pitfallsA Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma VirusesEurogin 2016 Roadmap: how HPV knowledge is changing screening practice.Evaluating a Quality Improvement Program for Cervical Cancer Screening at an Urban Safety Net Clinic.Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.The Interpretive Variability of Cervical Biopsies and Its Relationship to HPV Status.Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population."Low-grade squamous intraepithelial lesion, cannot exclude high-grade:" TBS says "Don't Use It!" should I really stop it?Cervical premalignant lesions and their management.Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelinesReassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theChromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications.Automated recommendation for cervical cancer screening and surveillance.Sexually transmitted diseases treatment guidelines, 2015.Patients with AIDS-defining cancers are not universally screened for HIV: a 10-year retrospective analysis of HIV-testing practices in a Swiss university hospital.Natural history of histologically moderate cervical dysplasia in adolescent and young women.Meta-analysis of cold-knife conization versus loop electrosurgical excision procedure for cervical intraepithelial neoplasiaClinical application of DNA ploidy to cervical cancer screening: A review.Multiple biopsies and detection of cervical cancer precursors at colposcopy.A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening resultsClinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screening.Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests.Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance.Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia.Clinical Implication of p16, Ki-67, and Proliferating Cell Nuclear Antigen Expression in Cervical Neoplasia: Improvement of Diagnostic Accuracy for High-grade Squamous Intraepithelial Lesion and Prediction of Resection Margin Involvement on ConizatiIssues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era.Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.Residual disease and risk factors in patients with high-grade cervical intraepithelial neoplasia and positive margins after initial conization.Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection ProgramGranular Quality Reporting for Cervical Cytology Testing.Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern ThailandCervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.
P2860
Q26748510-0577F947-2FED-4712-BCC6-71FD1C845EDDQ26798416-D80A0B0C-63EF-45D9-9820-9B95C1B7E549Q26827938-EABE9CE3-6D7F-43A7-9C1E-3C9B0E9BA672Q27001043-D1E4FDED-6818-4B1E-92A5-FD06BE7AAEB5Q28072431-8D57044C-5CBC-47C9-8B79-44D29042B974Q28550190-30F0D52E-BD49-4266-97E2-2EAF127F57EAQ30239987-5EECA844-2D83-4336-9134-D9018A57663DQ30279252-062A1D34-BBD4-409F-A900-D7D657B490E5Q30299986-51B9C434-D6D7-4D2F-8DE6-9484236D5530Q30300922-0F40870B-DE35-4BC8-B27C-45AC7AB0746FQ30301116-8EF3D1FC-4966-4CB3-A196-0E4FADF7241AQ33762507-BEB863CA-339A-470B-B06F-6191EC0EAFC3Q33811830-C3B4D0A9-1B0A-45F6-BDE1-C0B56BFA8AF1Q33822258-D7AFA48C-FB36-49BA-8962-A6563D36DDBEQ33951517-156A2BD9-A506-4E3C-80AE-EE47912F2812Q34212799-65E22C4A-8762-4D75-ACAC-B659657722D6Q34394449-FF7E15E2-6D8B-4067-A69D-C60BDE22D26FQ34428256-928A13D4-12F8-4ECB-AA1D-0F4B0684CF63Q34479272-A3D29506-3FA8-4478-82D5-5239CED014DDQ34516495-C8F94E37-B390-4097-991E-091D3F5033E9Q34532180-D1600561-B1AB-4E78-9FD2-50569B53F136Q34534219-1CAC3E7C-4C94-4242-8036-C15BDB422256Q34657755-B25AFF26-ACAA-426C-97D5-89FFB15574DAQ34716608-9FD0E46D-8CB3-46FE-8419-DFBAD6224E19Q34916671-02526393-2CF2-4AE7-9349-AA890FCE1FCAQ35036313-E7082A9E-74CA-4E4F-92A6-DF9274A62BE8Q35108590-2C6638AD-7607-4842-BEBF-7B696EECDD3DQ35168212-8968A68D-D336-4F86-9BFA-99D221528435Q35193205-7135D97D-B31E-422B-A4F4-432D308DE86EQ35198219-32D49BE6-3F20-43DF-B3A8-02AFD26779AFQ35203251-258A62E8-0F89-4F93-A47F-DAE07F8112ACQ35261428-16862616-4837-44E8-A87B-54EEAEA738B2Q35605607-9AA3EB68-3241-40CB-995B-6B717FC2999EQ35606989-04BEFCBA-37F9-473D-80C8-C18E63AC740FQ35653638-FA8CB220-1B8E-498D-B8CA-EAE24B26F2FBQ35665790-7FD71C0B-22F7-4916-9C41-23E5E676E09FQ35694177-93D7276F-3EA0-4E35-B10B-797A2F9E2722Q35917191-D0F3182D-20B8-4A1E-8FAC-1589CCC70B68Q36060165-9F7A2200-A536-44B6-917E-4F874D0F2C6BQ36187634-5165766C-C3A9-4F09-803C-BBDD28670831
P2860
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
2012 updated consensus guideli ...... g tests and cancer precursors.
@en
type
label
2012 updated consensus guideli ...... g tests and cancer precursors.
@en
prefLabel
2012 updated consensus guideli ...... g tests and cancer precursors.
@en
P2093
P1476
2012 updated consensus guideli ...... g tests and cancer precursors.
@en
P2093
2012 ASCCP Consensus Guidelines Conference
Diane Solomon
Herschel W Lawson
Hormuzd A Katki
L Stewart Massad
Mark H Einstein
Walter K Kinney
Warner K Huh
P304
P356
10.1097/LGT.0B013E318287D329
P433
P577
2013-04-01T00:00:00Z